Inositols act as second messengers in insulin signalling. In PCOS, where insulin resistance is common, randomised trials of myo-inositol have reported improved ovulation rates, more regular cycles and better insulin markers over three to six months.
The 40:1 myo to D-chiro ratio mirrors the ratio found in healthy human plasma and is the ratio used in most modern trials. Typical dosing is 2,000 mg of myo-inositol twice daily.
Inositol is not a substitute for a PCOS diagnosis or for prescription treatment where it is indicated. It sits alongside clinical care, not instead of it.